252 related articles for article (PubMed ID: 32816392)
1. Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes.
Alzaid F; Julla JB; Diedisheim M; Potier C; Potier L; Velho G; Gaborit B; Manivet P; Germain S; Vidal-Trecan T; Roussel R; Riveline JP; Dalmas E; Venteclef N; Gautier JF
EMBO Mol Med; 2020 Oct; 12(10):e13038. PubMed ID: 32816392
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol supplementation decreases blood glucose without changing the circulating CD14
Khodabandehloo H; Seyyedebrahimi S; Esfahani EN; Razi F; Meshkani R
Nutr Res; 2018 Jun; 54():40-51. PubMed ID: 29914666
[TBL] [Abstract][Full Text] [Related]
3. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
[TBL] [Abstract][Full Text] [Related]
4. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation.
Bonnet B; Cosme J; Dupuis C; Coupez E; Adda M; Calvet L; Fabre L; Saint-Sardos P; Bereiziat M; Vidal M; Laurichesse H; Souweine B; Evrard B
EBioMedicine; 2021 Nov; 73():103622. PubMed ID: 34678611
[TBL] [Abstract][Full Text] [Related]
5. Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients.
Teixeira PC; Dorneles GP; Santana Filho PC; da Silva IM; Schipper LL; Postiga IAL; Neves CAM; Rodrigues Junior LC; Peres A; Souto JT; Fonseca SG; Eller S; Oliveira TF; Rotta LN; Thompson CE; Romão PRT
Int Immunopharmacol; 2021 Nov; 100():108125. PubMed ID: 34543980
[TBL] [Abstract][Full Text] [Related]
6. Persistent Oxidative Stress and Inflammasome Activation in CD14
Lage SL; Amaral EP; Hilligan KL; Laidlaw E; Rupert A; Namasivayan S; Rocco J; Galindo F; Kellogg A; Kumar P; Poon R; Wortmann GW; Shannon JP; Hickman HD; Lisco A; Manion M; Sher A; Sereti I
Front Immunol; 2021; 12():799558. PubMed ID: 35095880
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review.
Ferguson M; Vel J; Phan V; Ali R; Mabe L; Cherner A; Doan T; Manakatt B; Jose M; Powell AR; McKinney K; Serag H; Sallam HS
Metab Syndr Relat Disord; 2023 May; 21(4):177-187. PubMed ID: 37130311
[TBL] [Abstract][Full Text] [Related]
8. Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States.
Ando W; Horii T; Uematsu T; Hanaki H; Atsuda K; Otori K
Sci Rep; 2021 Sep; 11(1):17968. PubMed ID: 34504112
[TBL] [Abstract][Full Text] [Related]
9. Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes.
Sun Y; Zhao R; Hu Z; Wang W; Wang S; Gao L; Fei J; Jian X; Li Y; Zheng H; Hou X; Chen L
J Diabetes Res; 2020; 2020():1038585. PubMed ID: 33376750
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.
Cheng Y; Yue L; Wang Z; Zhang J; Xiang G
J Diabetes Complications; 2021 Feb; 35(2):107809. PubMed ID: 33288414
[TBL] [Abstract][Full Text] [Related]
11. Selective expansion of pro-inflammatory chemokine CCL2-loaded CD14+CD16+ monocytes subset in HIV-infected therapy naïve individuals.
Ansari AW; Meyer-Olson D; Schmidt RE
J Clin Immunol; 2013 Jan; 33(1):302-6. PubMed ID: 22961048
[TBL] [Abstract][Full Text] [Related]
12. Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection.
Romão PR; Teixeira PC; Schipper L; da Silva I; Santana Filho P; Júnior LCR; Peres A; Gonçalves da Fonseca S; Chagas Monteiro M; Lira FS; Andrey Cipriani Frade M; Comerlato J; Comerlato C; Sant'Anna FH; Bessel M; Abreu CM; Wendland EM; Dorneles GP
Int Immunopharmacol; 2022 Jul; 108():108697. PubMed ID: 35405594
[TBL] [Abstract][Full Text] [Related]
13. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
14. A low level of CD16
Vasse M; Zuber B; Goubeau L; Ballester MC; Roumier M; Delcominette F; Habarou F; Jolly E; Ackermann F; Cerf C; Farfour E; Pascreau T;
Clin Chem Lab Med; 2021 Jun; 59(7):1315-1322. PubMed ID: 33606928
[TBL] [Abstract][Full Text] [Related]
15. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the immune response in coronavirus disease 2019.
Mohamed Khosroshahi L; Rezaei N
Cell Biol Int; 2021 Apr; 45(4):702-707. PubMed ID: 33289192
[TBL] [Abstract][Full Text] [Related]
17. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
Zhao R; Sun Y; Zhang Y; Wang W; Wang S; Wang C; Liu J; Gao L; Hu Z; Fei J; Hou X; Zheng H; Chen L
Mediators Inflamm; 2020; 2020():6914878. PubMed ID: 33061829
[TBL] [Abstract][Full Text] [Related]
18. Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.
Vigón L; Fuertes D; García-Pérez J; Torres M; Rodríguez-Mora S; Mateos E; Corona M; Saez-Marín AJ; Malo R; Navarro C; Murciano-Antón MA; Cervero M; Alcamí J; García-Gutiérrez V; Planelles V; López-Huertas MR; Coiras M
Front Immunol; 2021; 12():665329. PubMed ID: 34122423
[TBL] [Abstract][Full Text] [Related]
19. Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.
Charoenngam N; Alexanian SM; Apovian CM; Holick MF
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206813
[TBL] [Abstract][Full Text] [Related]
20. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
Sun DW; Zhang D; Tian RH; Li Y; Wang YS; Cao J; Tang Y; Zhang N; Zan T; Gao L; Huang YZ; Cui CL; Wang DX; Zheng Y; Lv GY
Clin Chim Acta; 2020 Sep; 508():122-129. PubMed ID: 32417210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
